ConductScience.org, home

Paper40940959

Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.

Skribek B and 10 others. Cancers (Basel), 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. Papers, record 40940959. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40940959

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-09-16
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Skribek BBenjamin
2Szabó AAnett
3Ács JJúlia
4Cavalcante BGNBianca Golzio Navarro
5Sipos BDBoglárka Dorina
6Hegyi PPéter
7Mátrai PPéter
8Nyirády PPéter
9Ács NNándor
10Majoros AAttila
11Deák PÁPál Ákoshttps://orcid.org/0000-0003-3881-837X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References118

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130768957Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome.Magn Reson Imaging2019https://conductscience.org/library/papers/30768957PubMed
226951947Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.Eur Urol2016https://conductscience.org/library/papers/26951947PubMed
319638912The Clavien-Dindo classification of surgical complications: five-year experience.Ann Surg2009https://conductscience.org/library/papers/19638912PubMed
429107031Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.J Urol2018https://conductscience.org/library/papers/29107031PubMed
536073928Focal Therapy of Prostate Cancer Index Lesion With Irreversible Electroporation. A Prospective Study With a Median Follow-up of 3 Years.J Urol2023https://conductscience.org/library/papers/36073928PubMed
621354037[Outcomes of HIFU for localised prostate cancer using the Ablatherm Integrate Imaging® device].Prog Urol2011https://conductscience.org/library/papers/21354037PubMed
716857310Control of prostate cancer by transrectal HIFU in 227 patients.Eur Urol2007https://conductscience.org/library/papers/16857310PubMed
817572198Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.Urology2007https://conductscience.org/library/papers/17572198PubMed
933926838Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance.Eur Urol Focus2022https://conductscience.org/library/papers/33926838PubMed
1022928703Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.BJU Int2012https://conductscience.org/library/papers/22928703PubMed
1132701978Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre.PLoS One2020https://conductscience.org/library/papers/32701978PubMed
1233529137MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.Radiology2021https://conductscience.org/library/papers/33529137PubMed
1333492425Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.World J Urol2022https://conductscience.org/library/papers/33492425PubMed
1439468217Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?-a systematic review and meta-analysis.Prostate Cancer Prostatic Dis2025https://conductscience.org/library/papers/39468217PubMed
1529223469Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis.Eur J Surg Oncol2018https://conductscience.org/library/papers/29223469PubMed
1623092060Interrater reliability: the kappa statistic.Biochem Med (Zagreb)2012https://conductscience.org/library/papers/23092060PubMed
1736910902Irreversible electroporation for prostate cancer using PSMA PET-CT.Prostate Int2023https://conductscience.org/library/papers/36910902PubMed
1833983695Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.Oncology (Williston Park)2021https://conductscience.org/library/papers/33983695PubMed
1931161973Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.Radiology2019https://conductscience.org/library/papers/31161973PubMed
2032562361Optimally estimating the sample standard deviation from the five-number summary.Res Synth Methods2020https://conductscience.org/library/papers/32562361PubMed

See all 118 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NPEPPS9520PubTator's text mininghttps://conductscience.org/library/genes/9520

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40940959

GET https://conductscience.org/api/papers/v1/40940959/references?page=2